AdAlta Receives AU$0.73m R&D Tax Incentive
Read More
Becoming a substantial holder
Read More
Becoming a substantial holder
Read More
Becoming a substantial holder
Read More
Becoming a substantial holder
Read More
Investor Presentation
Read More
AdAlta IPO to Accelerate New Therapy for Lung Fibrosis
Read More
Initial Director’s Interest Notice
Read More
Initial Director’s Interest Notice
Read More
Initial Director’s Interest Notice
Read More